kabutan

Human Metabolome Technologies, Inc.(6090) Summary

6090
TSE Standard
Human Metabolome Technologies, Inc.
651
JPY
+7
(+1.09%)
Dec 5, 2:15 pm JST
4.20
USD
Dec 5, 12:15 am EST
Result
PTS
outside of trading hours
659
Dec 5, 1:07 pm JST
Summary Chart Historical News Financial Result
PER
14.0
PBR
2.17
Yield
2.76%
Margin Trading Ratio
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
645 JPY 4.15 USD
Previous Close Dec 4
644 JPY 4.14 USD
High Dec 5, 1:10 pm
659 JPY 4.24 USD
Low Dec 5, 9:00 am
645 JPY 4.15 USD
Volume
6,500
Trading Value
4.00M JPY 0.03M USD
VWAP
651.25 JPY 4.2 USD
Minimum Trading Value
65,100 JPY 420 USD
Market Cap
3.85B JPY 0.03B USD
Number of Trades
28
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Slightly Low
1-Year Average
36
1-Year High Jul 1, 2025
282
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 0 222,900
Nov 21, 2025 0 223,200
Nov 14, 2025 0 227,800
Nov 7, 2025 0 227,400
Oct 31, 2025 0 228,900
Company Profile
Human Metabolome Technologies, Inc. is a biotech venture company originating from Keio University. The company specializes in metabolite analysis services and biomarker detection.
Sector
Services
Human Metabolome Technologies develops businesses utilizing metabolome analysis and biotechnology. Through its comprehensive metabolite analysis technology using CE-MS method, the company engages in two main business areas: advanced research and development support, and healthcare solutions. In the former, the company provides metabolome analysis services to food, chemical, and pharmaceutical companies, as well as research institutions. In the latter, it supports the development of functional materials.